Editor-Curated Robotics Industry Briefing - RobotToday

Multiply Labs Secures $75 Million in Series B Funding for Robotic Drug Manufacturing Expansion

Multiply Labs has successfully raised $75 million in Series B funding aimed at enhancing its robotic systems for automating manual processes in biologics manufacturing. This funding round was led by Dr. Patrick Soon-Shiong and NantWorks, with participation from new investors including AstraZeneca, Lingotto, Teradyne, and Strange Ventures. The significance of this funding lies in Multiply Labs' commitment to revolutionizing the biologics manufacturing sector through automation. By streamlining manual steps with advanced robotic technology, the company aims to improve efficiency and reduce costs in drug production, which is crucial for meeting the growing demand for biologics. Looking ahead, industry observers will be keen to see how Multiply Labs utilizes this funding to scale its operations and further develop its robotic systems. No further timeline was disclosed at the time of publication.

AIInsider By Greg Bock 12 hours ago AI Funding & Investment Physical AI AI AstraZeneca biologics Casdin Capital

Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs

Roche has announced the deployment of over 3,500 NVIDIA Blackwell GPUs across its global operations, significantly enhancing its research and development productivity, next-generation diagnostics, and manufacturing efficiencies. This strategic move aims to integrate advanced computing capabilities throughout the entire value chain, thereby accelerating innovation and improving operational performance. The initiative reflects Roche's commitment to leveraging cutting-edge technology to drive advancements in healthcare and streamline its processes.

NvidiaNews By NVIDIA Mar 16, 2026